UPDATE: Benchmark Assumes MaxLinear (MXL) at Buy

Go back to UPDATE: Benchmark Assumes MaxLinear (MXL) at Buy

MaxLinear (MXL) PT Raised to $54 at Needham & Company

July 29, 2021 7:23 AM EDT

Needham & Company analyst N. Quinn Bolton raised the price target on MaxLinear (NYSE: MXL) to $54.00 (from $50.00) while maintaining a Buy rating.

The analyst commented, "MaxLinear reported solid 2Q21 results and provided 3Q21 revenue and GM guidance that exceeded expectations. With 2Q21 GM of 60.2%,... More

MaxLinear (MXL) PT Raised to $45 at Deutsche Bank

July 29, 2021 6:53 AM EDT

Deutsche Bank analyst Ross Seymore raised the price target on MaxLinear (NYSE: MXL) to $45.00 (from $40.00) while maintaining a Hold rating.... More

MaxLinear (MXL) PT Raised to $45 at Susquehanna

July 29, 2021 6:48 AM EDT

Susquehanna analyst Christopher Rolland raised the price target on MaxLinear (NYSE: MXL) to $45.00 (from $37.00) while maintaining a Neutral rating.... More

MaxLinear (MXL) PT Raised to $45 at Wells Fargo

July 29, 2021 6:36 AM EDT

Wells Fargo raised its price target on MaxLinear (NYSE: MXL) to $45.00 (from $35.00) while maintaining a Equal Weight rating.... More

MaxLinear (MXL) Tops Q2 EPS by 3c

July 28, 2021 4:10 PM EDT

MaxLinear (NYSE: MXL) reported Q2 EPS of $0.53, $0.03 better than the analyst estimate of $0.50. Revenue for the quarter came in at $205.4 million versus the consensus estimate of $204.75 million.

GUIDANCE:

MaxLinear sees Q3 2021 revenue of $215-225 million, versus the consensus of $202.7... More